In the last trading session, 2.29 million shares of the Vir Biotechnology Inc (NASDAQ:VIR) were traded, and its beta was 0.47. Most recently the company’s
In the last trading session, 2.24 million shares of the Vir Biotechnology Inc (NASDAQ:VIR) were traded, and its beta was 0.49. Most recently the company’s
Vir Biotechnology Inc (NASDAQ:VIR)’s traded shares stood at 1.48 million during the last session, with the company’s beta value hitting 0.50. At the close of
In the last trading session, 1.09 million Vir Biotechnology Inc (NASDAQ:VIR) shares changed hands as the company’s beta touched 0.55. With the company’s per share
Vir Biotechnology Inc (NASDAQ:VIR) has a beta value of 0.47 and has seen 1.11 million shares traded in the last trading session. The company, currently
Vir Biotechnology Inc (NASDAQ:VIR) has a beta value of 0.47 and has seen 1.55 million shares traded in the last trading session. The company, currently
During the recent session, Vir Biotechnology Inc (NASDAQ:VIR)’s traded shares were 4.22 million, with the beta value of the company hitting 0.46. At the last
Vir Biotechnology, Inc. (NASDAQ: VIR) stock is up 8.19% in the premarket to trade at the price of $42.00 after the release of the second-quarter
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
